DREA — I had 3 surgeries to remove nasal polyps and I'm not improving — Could it be DREA?
When symptoms or doubts arise involving DREADistinguishing between scientifically validated information and palliative care makes all the difference in the evolution of respiratory, skin, and systemic health. This page aims to deepen understanding of... "DREA — I had 3 surgeries to remove nasal polyps and I'm not improving — Could it be DREA?", providing clear context on how the immune system reacts, which signs require medical attention, and how to structure individualized and effective care.
Complementary Audiovisual Content: Click here to watch the full explanatory video on the official Brasil Sem Alergia YouTube channel..
✔ Medical content reviewed and validated by the founding clinical staff of the Brazil Without Allergies Project
Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.
Understanding the Relationship Between Recurrent Nasal Polyps and Aspirin-Exacerbated Respiratory Disease (AED)
One of the major challenges in the clinical practice of Allergy and Immunology is the management of patients who present with recurrent episodes of nasal polyps associated with asthma, often undergoing multiple surgical interventions without achieving the expected clinical relief. This frequent therapeutic frustration may be related to a specific and still underdiagnosed condition: Aspirin-Exacerbated Respiratory Disease (AERD). When the patient reports successive surgeries to remove nasal polyps without lasting improvement, it is essential to investigate the presence of hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin and similar drugs.
Establishing a causal link is not always simple. In many cases, the patient has not recently used aspirin, but the sensitization process occurred years before and remains active, perpetuating chronic airway inflammation and the continuous formation of polyps. Given this complex scenario, specialized medical investigation becomes essential to confirm the diagnosis and determine the best therapeutic approach.
Diagnostic and Therapeutic Approaches in DREA
To confirm a diagnosis of Aspirin-Exacerbated Respiratory Disease, the specialist physician may use specific procedures:
- Provocation Test: Performed in a monitored hospital setting to assess the body's reaction to the medication under direct supervision.
- Desensitization: It is indicated when there is a strong causal link, allowing the patient to regain tolerance to the medication or minimize severe inflammatory flare-ups.
In addition to desensitization with acetylsalicylic acid—a procedure that rigorously requires a highly complex hospital unit—medical advances have brought new therapeutic perspectives. The use of monoclonal antibodies, such as dupilumab (a biological agent that blocks interleukins 4 and 13, central mediators of the allergic response), has demonstrated effectiveness in preventing the appearance of new nasal polyps. It is worth noting that, although polyps that have already formed and are active require surgical removal, biological treatments significantly assist in long-term preventive control.
Important note: This content is for educational and informational purposes only and does not, under any circumstances, replace consultation, diagnosis, and individualized medical follow-up with a specialist from the Brazil Without Allergies Project or one you trust.
Developments in Evidence-Based Medicine: Pharmacology of Immunobiologics and Precision Medicine
In Evidence-Based Medicine, the indication of immunobiological agents (monoclonal antibodies and receptor fusion proteins) It is based on the patient's inflammatory endotyping. Selective blocking of molecular targets — such as the neutralization of free IgE by omalizumab (in severe allergic asthma and chronic spontaneous urticaria refractory to quadrupled-dose H1 antihistamines), the dual inhibition of IL-4 and IL-13 interleukin signaling by dupilumab (In moderate to severe atopic dermatitis, eosinophilic/Th2 asthma, and chronic rhinosinusitis with nasal polyposis), the blockade of the TSLP epithelial alarm by tezepelumab or blocking the IL-5/IL-5R pathway — allows control of the inflammatory cascade at its cellular origin, reducing exacerbations and sparing the patient from the adverse metabolic, endocrine, and cardiovascular effects of prolonged systemic corticosteroid use.
💎 Diamond Plan — Recurrent sinusitis often has a treatable allergic cause at its root. Speak with an Allergy and Immunology specialist via teleconsultation, from anywhere in Brazil. Schedule a teleconsultation →
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Unified Airway: Management of Rhinitis, Rhinosinusitis, and Nasal Hypersensitivity
Inflammation of the Respiratory Mucosa, House Mites, and Local Complications
The nose performs vital functions of filtering, warming, and humidifying inhaled air before it reaches the lungs. In allergic rhinitis and chronic rhinosinusitis, contact between aeroallergens—especially house dust mites (Dermatophagoides pteronyssinus and Blomia tropicalis), anemophilous fungi, and epithelia—and IgE antibodies fixed to mast cells in the nasal mucosa triggers the immediate release of histamine, leukotrienes, and prostaglandins. This process generates nasal obstruction, itching, sneezing fits, post-nasal drip (a frequent cause of chronic nighttime cough), and vascular fragility that can favor minor bleeding (epistaxis) due to trauma from blowing the nose or from poorly directed sprays.
Nasal Irrigation, Safe Topical Sprays, and Desensitizing Immunotherapy
Environmental hygiene measures in the bedroom — waterproofing of mattresses and pillows, solar ventilation, and removal of dust reservoirs — go hand in hand with the allergy test and the rhinitis treatment individualized. When indicated by the specialist, the allergy vaccine It reduces nasal congestion in a lasting way and prevents the progression to recurrent sinusitis and bronchial hyperreactivity.
Lower Airway Hyperreactivity and the Role of Inhalation Therapy
Objective monitoring through spirometry (pulmonary function test with bronchodilator test) is indispensable even during periods when the patient believes they are asymptomatic, as it detects silent obstructions in small airways. Modern inhaled corticosteroids act directly on the respiratory mucosa in doses measured in micrograms, offering high systemic safety, reducing severe exacerbations, and protecting respiratory capacity in the long term.
Immediate Reactions, Delayed Drug Reactions, and Risks of Self-Medication
Drug hypersensitivity reactions encompass distinct immunological and pharmacological mechanisms: from immediate reactions (up to one to six hours after dosing, manifested by urticaria, labial or palpebral angioedema, bronchospasm, and anaphylaxis, common with COX-1 inhibitor analgesics and beta-lactams) to delayed drug eruptions mediated by T cells, such as maculopapular rashes and DRESS syndrome — a systemic condition that arises weeks after the start of anticonvulsants, sulfones, or allopurinol, presenting with fever, lymphadenomegaly, eosinophilia, and the need for immediate discontinuation under hospital supervision.
Selective Blockade of Cytokines (IL-4, IL-5, IL-13, TSLP) and Immunoglobulin E
Choosing the ideal immunobiological agent requires rigorous phenotyping and endotyping by a specialist physician, evaluating blood biomarkers (peripheral eosinophil count, serum levels of total IgE and exhaled fraction of nitric oxide) and coexisting comorbidities, such as severe asthma, nasal polyposis, refractory chronic spontaneous urticaria, and moderate to severe atopic dermatitis. Subcutaneous applications follow a regular schedule under safe clinical supervision.
Clinical Safety Criteria and Warning Signs in Allergology
Early recognition of warning signs requiring priority medical reassessment is part of the health education of every patient and their family. Symptoms such as progressive dyspnea (difficulty breathing or speaking in complete sentences), refractory wheezing, sudden edema of the lips, tongue, or glottis, dizziness due to a drop in blood pressure, persistent fever associated with skin lesions or mucous membrane involvement require immediate emergency care, followed by a structured allergy investigation to prevent future recurrences.
Diamond Plan: Specialized Allergy Treatment Wherever You Are
Living hundreds of miles from an allergist or having to interrupt treatment because of the price of vaccines shouldn't be anyone's fate. With the Diamond PlanBrazil Without Allergies brings the same high standard of care from its clinics to your home, with telemedicine consultations and a more accessible path to immunotherapy. Recurrent sinusitis often has a treatable allergic cause at its root.
Why do patients across Brazil choose the Diamond Plan?
- Teleconsultation with a specialist In Allergy and Immunology, without queues and without long commutes — ideal for those who live far from large cities.
- easy access to Immunotherapy (including allergy vaccines and immunostimulants) — indicated for the treatment of allergic rhinitis, asthma, bronchitis, atopic dermatitis, insect/mosquito bite allergy (prurigo strophulus), recurrent candidiasis, and for increasing immunity in selected patients — capable of modifying the natural course of allergic disease, always through consultation and individualized prescription.
- A more accessible route For those facing the high cost of allergy vaccines, this plan offers support for continuity of treatment.
- Continuous monitoring based on clinical evolution, with adjustments to treatment throughout the entire therapeutic cycle.
- National coverage, backed by a consolidated physical network and a founding clinical team with over three decades of experience.
More than 30 years caring for people with allergies.
Founded and run by Dr. Marcello Bossois (CRM-RJ 52.73214-1) and by Dr. Patrícia Schlinkert (CRM/RJ 5274541-3)The Brazil Without Allergies Project adds... more than 30 years of history and more than 450,000 free services, with physical presence at Rio de Janeiro, São Paulo and Paraná, one mobile clinic bus that brings testing and consultations to communities with limited access to specialized care and a platform of telemedicine which connects patients from all states to the same standard of care.
START TODAY
Your expert consultation is just a click away.
I want to join the Diamond Plan.Schedule a teleconsultation
Official telemedicine environment: brasilsemalergia.online
Do you prefer to be served in person?
Our clinical units They conduct consultations, allergy tests, and immunotherapy follow-up with doctors in person:
- Rio de Janeiro: Realengo (West Zone), North Zone, Duke of Caxias, Xerém, New Iguaçu, Itaguaí, Niterói, Iguaba Grande and Saint Peter of the Village (Lakes Region).
- São Paulo: Campo Limpo (South Zone).
- Paraná: Curitiba.
Schedule your in-person appointment. Or check the mobile bus schedule through the customer service center on WhatsApp. (21) 99954-5632.
The indication for immunotherapy, and for any treatment, depends on an individual medical evaluation. This content is for informational purposes only and does not replace consultation with a specialist.
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Conclusion and Summary of Guidelines
In summary, the appropriate approach to DREA It requires a clear understanding of the immunological mechanisms involved, precise etiological diagnosis, and individualized medical follow-up. Avoiding self-medication and investigating the root cause of symptoms—relying on specialized resources and reliable guidance such as specialized allergy and immunology care when clinically relevant—is the safest way to control flare-ups, prevent complications, and ensure sustainable quality of life.
Scientific references and authoritative sources
The guidelines on this page follow the guidelines and literature of leading international Allergy and Immunology institutions. For further information:




